Today Paresh Vyas is Professor of Haematology and Honorary Consultant Haematologist as well as Group Leader at the MRC Molecular Haematology Unit in Oxford, UK. He runs a clinical practice in myeloid disorders (especially Acute Myeloid Leukaemia) and has research interests including haematological defect in MDS and AML, in adults and children with Down Syndrome.
He first studied medicine at Cambridge University, before moving on to the other place – Oxford University. There he did a PhD studying the control of gene regulation with Professor Doug Higgs and Professor Sir David Weatherall and then completed his specialist training in Haematology at the Royal Free Hospital, London under Professors Victor Hoffbrand, Grant Prentice and Atul Metha. It was at Harvard University that he developed a long-term interest in understanding the molecular basis of haematological disease – working with Professor Stuart Orkin.
His biggest thrill was seeing the publication of his first paper and Paresh understands the importance of bringing such opportunities to young scientists. That’s one of the reasons for his active support of The Company of Biologists.
“The Company of Biologists is an independent not-for-profit organisation that promotes the best and encourages all, especially aspiring scientists. It represents true ideals in promoting scientific knowledge.”
Paresh Vyas, MRCP, FRCP, FRCPath, Director